New Phase Israeli Company

New Phase has developed a therapeutic cancer-treatment technology based on hyperthermia. Cancer cells are generally more sensitive to exposure to temperatures between 41C to 45C than normal cells, primarily due to the complexity of the vascular architecture in solid tumors.